Spero Therapeutics, Inc. (SPRO) Financials
SPRO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 182.4 million | 75.5 million |
2023-09-30 | 107.1 million | 53.4 million |
2023-06-30 | 98.9 million | 44.1 million |
2023-03-31 | 112.5 million | 47.7 million |
SPRO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -17.5 million | 2.0 million |
2023-09-30 | 15.9 million | 1.9 million |
2023-06-30 | -18.6 million | 1.9 million |
2023-03-31 | -12.9 million | 2.2 million |
SPRO Net Income
No data available :(
SPRO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 76.3 million | - | 5.5 million |
2023-09-30 | 93.8 million | - | 5.8 million |
2023-06-30 | 77.7 million | - | 6.1 million |
2023-03-31 | 96.3 million | 85000 | 6.4 million |
SPRO Shares Outstanding
SPRO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 16.5 million | 6.4 million | - |
2023-09-30 | - | 16.4 million | 5.7 million | - |
2023-06-30 | - | 9.5 million | 6.1 million | - |
2023-03-31 | - | 9.0 million | 7.3 million | - |
SPRO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 71.8 million | 38000 |
2023-09-30 | 25.5 million | 108000 |
2023-06-30 | 788000 | 9.5 million |
2023-03-31 | 740000 | 9.0 million |
SPRO
Price: $1.66
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.43 USD
P/E Ratio: 3.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 179389
Market Capitalization: 88.9 million
Average Dividend Frequency: 4